Photodynamic therapy in superficial bladder cancer: past, present and future.

Jichlinski P; Leisinger HJ

doi:10.1007/s002400100215

Back

Journal article

Photodynamic therapy in superficial bladder cancer: past, present and future.

Jichlinski P Department of Urology, University Hospital, CHUV, Lausanne, Switzerland. Patrice.Jichlinski@chuv.hospvd.ch
Leisinger HJ

2002-02-07

Published in:

Urological research. - 2001

English For many reasons, such as toxicity and lack of selectivity of photosensitisers, as well as complexity of technical procedures and inconstant therapeutic results, photodynamic therapy of highly recurrent superficial bladder cancer never gained wide acceptance in the urological community. However, the 25 years of experience combined with the recent discovery of new photosensitisers, such as protoporphyrin IX (PpIX) induced by 5-aminolevulinic acid (ALA) or ALA-derivatives or hypericin open new, very interesting perspectives in this therapeutic field.

Language